Skip to main content
Erschienen in:

12.09.2023 | Original Article

Osteosarcopenia is a significant predictor of recurrence and the prognosis after resection for extrahepatic bile duct cancer

verfasst von: Michinori Matsumoto, Shinji Onda, Yosuke Igarashi, Ryoga Hamura, Tadashi Uwagawa, Kenei Furukawa, Yoshihiro Shirai, Takeshi Gocho, Koichiro Haruki, Toru Ikegami

Erschienen in: Surgery Today | Ausgabe 5/2024

Einloggen, um Zugang zu erhalten

Abstract

Purpose

This study examined the impact of osteosarcopenia on recurrence and the prognosis after resection for extrahepatic biliary tract cancer (EBTC).

Methods

We retrospectively analyzed 138 patients after resection for perihilar cholangiocarcinoma (11), distal cholangiocarcinoma (54), gallbladder carcinoma (30), or ampullary carcinoma (43). Osteosarcopenia is defined as the concomitant occurrence of osteopenia and sarcopenia. We investigated the relationship between osteosarcopenia and the overall survival (OS) and disease-free survival (DFS) in univariate and multivariate analyses.

Results

Osteosarcopenia was identified in 38 patients (27.5%) before propensity score (PS) matching. In the multivariate analysis, the independent recurrence factors were the prognostic nutrition index (p = 0.015), osteosarcopenia (p < 0.001), poorly differentiated adenocarcinoma (p = 0.004), perineural invasion (p = 0.002), and non-curability (p = 0.008), whereas the independent prognostic factors were prognostic nutrition index (p = 0.030), osteosarcopenia (p < 0.001), poorly differentiated adenocarcinoma (p = 0.007), lymphatic invasion (p = 0.018), and non-curability (p = 0.004). After PS matching, there was no significant difference in the variables between the patients with and without osteosarcopenia (n = 34 each). The 5-year DFS and OS after PS matching in patients with osteosarcopenia were significantly worse than in patients without osteosarcopenia (17.6% vs. 38.8%, p = 0.013 and 20.6% vs. 57.4%, p = 0.0005, respectively).

Conclusions

Preoperative osteosarcopenia could predict the DFS and OS of patients after resection for EBTC.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat Valle JW, Kelley RK, Nervi B, Oh DY, Zhu AX. Biliary tract cancer. Lancet. 2021;397:428–44.CrossRefPubMed Valle JW, Kelley RK, Nervi B, Oh DY, Zhu AX. Biliary tract cancer. Lancet. 2021;397:428–44.CrossRefPubMed
2.
Zurück zum Zitat Ishihara S, Horiguchi A, Miyakawa S, Endo I, Miyazaki M, Takada T. Biliary tract cancer registry in Japan from 2008 to 2013. J Hepatobiliary Pancreat Sci. 2016;23:149–57.CrossRefPubMed Ishihara S, Horiguchi A, Miyakawa S, Endo I, Miyazaki M, Takada T. Biliary tract cancer registry in Japan from 2008 to 2013. J Hepatobiliary Pancreat Sci. 2016;23:149–57.CrossRefPubMed
3.
Zurück zum Zitat Yao S, Kaido T, Okumura S, Iwamura S, Miyachi Y, Shirai H, et al. Bone mineral density correlates with survival after resection of extrahepatic biliary malignancies. Clin Nutr. 2019;38:2770–7.CrossRefPubMed Yao S, Kaido T, Okumura S, Iwamura S, Miyachi Y, Shirai H, et al. Bone mineral density correlates with survival after resection of extrahepatic biliary malignancies. Clin Nutr. 2019;38:2770–7.CrossRefPubMed
4.
Zurück zum Zitat Nakachi K, Konishi M, Ikeda M, Mizusawa J, Eba J, Okusaka T, et al. A randomized phase III trial of adjuvant S-1 therapy vs observation alone in resected biliary tract cancer: Japan Clinical oncology group study (JCOG1202, ASCOT). Jpn J Clin Oncol. 2018;48:392–5.CrossRefPubMed Nakachi K, Konishi M, Ikeda M, Mizusawa J, Eba J, Okusaka T, et al. A randomized phase III trial of adjuvant S-1 therapy vs observation alone in resected biliary tract cancer: Japan Clinical oncology group study (JCOG1202, ASCOT). Jpn J Clin Oncol. 2018;48:392–5.CrossRefPubMed
5.
Zurück zum Zitat Shachar SS, Williams GR, Muss HB, Nishijima TF. Prognostic value of sarcopenia in adults with solid tumours: a meta-analysis and systematic review. Eur J Cancer. 2016;57:58–67.CrossRefPubMed Shachar SS, Williams GR, Muss HB, Nishijima TF. Prognostic value of sarcopenia in adults with solid tumours: a meta-analysis and systematic review. Eur J Cancer. 2016;57:58–67.CrossRefPubMed
6.
Zurück zum Zitat Chakedis J, Spolverato G, Beal EW, Woelfel I, Bagante F, Merath K, et al. Pre-operative sarcopenia identifies patients at risk for poor survival after resection of biliary tract cancers. J Gastrointest Surg. 2018;22:1697–708.CrossRefPubMed Chakedis J, Spolverato G, Beal EW, Woelfel I, Bagante F, Merath K, et al. Pre-operative sarcopenia identifies patients at risk for poor survival after resection of biliary tract cancers. J Gastrointest Surg. 2018;22:1697–708.CrossRefPubMed
7.
Zurück zum Zitat Sepúlveda-Loyola W, Phu S, Bani Hassan E, Brennan-Olsen SL, Zanker J, Vogrin S, et al. The joint occurrence of osteoporosis and sarcopenia (osteosarcopenia): definitions and characteristics. J Am Med Dir Assoc. 2020;21:220–5.CrossRefPubMed Sepúlveda-Loyola W, Phu S, Bani Hassan E, Brennan-Olsen SL, Zanker J, Vogrin S, et al. The joint occurrence of osteoporosis and sarcopenia (osteosarcopenia): definitions and characteristics. J Am Med Dir Assoc. 2020;21:220–5.CrossRefPubMed
8.
Zurück zum Zitat Tamura S, Ashida R, Sugiura T, Okamura Y, Ito T, Yamamoto Y, et al. The prognostic impact of skeletal muscle status and bone mineral density for resected distal cholangiocarcinoma. Clin Nutr. 2021;40:3552–8.CrossRefPubMed Tamura S, Ashida R, Sugiura T, Okamura Y, Ito T, Yamamoto Y, et al. The prognostic impact of skeletal muscle status and bone mineral density for resected distal cholangiocarcinoma. Clin Nutr. 2021;40:3552–8.CrossRefPubMed
9.
Zurück zum Zitat Watanabe J, Saitsu A, Miki A, Kotani K, Sata N. Prognostic value of preoperative low bone mineral density in patients with digestive cancers: a systematic review and meta-analysis. Arch Osteoporos. 2022;17:33.CrossRefPubMedPubMedCentral Watanabe J, Saitsu A, Miki A, Kotani K, Sata N. Prognostic value of preoperative low bone mineral density in patients with digestive cancers: a systematic review and meta-analysis. Arch Osteoporos. 2022;17:33.CrossRefPubMedPubMedCentral
10.
Zurück zum Zitat Edwards BJ, Sun M, Zhang X, Holmes HM, Song J, Khalil P, et al. Fractures frequently occur in older cancer patients: the MD ANDERSON CANCER CENTer experience. Support Care Cancer. 2018;26:1561–8.CrossRefPubMed Edwards BJ, Sun M, Zhang X, Holmes HM, Song J, Khalil P, et al. Fractures frequently occur in older cancer patients: the MD ANDERSON CANCER CENTer experience. Support Care Cancer. 2018;26:1561–8.CrossRefPubMed
11.
Zurück zum Zitat Pereira FB, Leite AF, de Paula AP. Relationship between pre-sarcopenia, sarcopenia and bone mineral density in elderly men. Arch Endocrinol Metab. 2015;59:59–65.CrossRefPubMed Pereira FB, Leite AF, de Paula AP. Relationship between pre-sarcopenia, sarcopenia and bone mineral density in elderly men. Arch Endocrinol Metab. 2015;59:59–65.CrossRefPubMed
12.
Zurück zum Zitat Inoue T, Maeda K, Nagano A, Shimizu A, Ueshima J, Murotani K, et al. Related factors and clinical outcomes of osteosarcopenia: a narrative review. Nutrients. 2021;13:291.CrossRefPubMedPubMedCentral Inoue T, Maeda K, Nagano A, Shimizu A, Ueshima J, Murotani K, et al. Related factors and clinical outcomes of osteosarcopenia: a narrative review. Nutrients. 2021;13:291.CrossRefPubMedPubMedCentral
13.
Zurück zum Zitat Abe K, Furukawa K, Okamoto T, Matsumoto M, Futagawa Y, Haruki K, et al. Impact of osteopenia on surgical and oncological outcomes in patients with pancreatic cancer. Int J Clin Oncol. 2021;26:1929–37.CrossRefPubMed Abe K, Furukawa K, Okamoto T, Matsumoto M, Futagawa Y, Haruki K, et al. Impact of osteopenia on surgical and oncological outcomes in patients with pancreatic cancer. Int J Clin Oncol. 2021;26:1929–37.CrossRefPubMed
14.
Zurück zum Zitat Furukawa K, Haruki K, Taniai T, Hamura R, Shirai Y, Yasuda J, et al. Osteosarcopenia is a potential predictor for the prognosis of patients who underwent hepatic resection for colorectal liver metastases. Ann Gastroenterol Surg. 2021;5:390–8.CrossRefPubMedPubMedCentral Furukawa K, Haruki K, Taniai T, Hamura R, Shirai Y, Yasuda J, et al. Osteosarcopenia is a potential predictor for the prognosis of patients who underwent hepatic resection for colorectal liver metastases. Ann Gastroenterol Surg. 2021;5:390–8.CrossRefPubMedPubMedCentral
15.
Zurück zum Zitat Taniai T, Haruki K, Yanagaki M, Igarashi Y, Furukawa K, Onda S, et al. Osteosarcopenia predicts poor prognosis for patients with intrahepatic cholangiocarcinoma after hepatic resection. Surg Today. 2022;52:1524–31.PubMed Taniai T, Haruki K, Yanagaki M, Igarashi Y, Furukawa K, Onda S, et al. Osteosarcopenia predicts poor prognosis for patients with intrahepatic cholangiocarcinoma after hepatic resection. Surg Today. 2022;52:1524–31.PubMed
16.
Zurück zum Zitat Toshima T, Yoshizumi T, Kosai-Fujimoto Y, Inokuchi S, Yoshiya S, Takeishi K, et al. Prognostic impact of osteopenia in patients who underwent living donor liver transplantation for hepatocellular carcinoma. World J Surg. 2020;44:258–67.CrossRefPubMed Toshima T, Yoshizumi T, Kosai-Fujimoto Y, Inokuchi S, Yoshiya S, Takeishi K, et al. Prognostic impact of osteopenia in patients who underwent living donor liver transplantation for hepatocellular carcinoma. World J Surg. 2020;44:258–67.CrossRefPubMed
17.
Zurück zum Zitat Sharma P, Parikh ND, Yu J, Barman P, Derstine BA, Sonnenday CJ, et al. Bone mineral density predicts posttransplant survival among hepatocellular carcinoma liver transplant recipients. Liver Transpl. 2016;22:1092–8.CrossRefPubMedPubMedCentral Sharma P, Parikh ND, Yu J, Barman P, Derstine BA, Sonnenday CJ, et al. Bone mineral density predicts posttransplant survival among hepatocellular carcinoma liver transplant recipients. Liver Transpl. 2016;22:1092–8.CrossRefPubMedPubMedCentral
18.
Zurück zum Zitat Yugawa K, Itoh S, Kurihara T, Yoshiya S, Mano Y, Takeishi K, et al. Skeletal muscle mass predicts the prognosis of patients with intrahepatic cholangiocarcinoma. Am J Surg. 2019;218:952–8.CrossRefPubMed Yugawa K, Itoh S, Kurihara T, Yoshiya S, Mano Y, Takeishi K, et al. Skeletal muscle mass predicts the prognosis of patients with intrahepatic cholangiocarcinoma. Am J Surg. 2019;218:952–8.CrossRefPubMed
19.
Zurück zum Zitat Forrest LM, McMillan DC, McArdle CS, Angerson WJ, Dunlop DJ. Evaluation of cumulative prognostic scores based on the systemic inflammatory response in patients with inoperable non-small-cell lung cancer. Br J Cancer. 2003;89:1028–30.CrossRefPubMedPubMedCentral Forrest LM, McMillan DC, McArdle CS, Angerson WJ, Dunlop DJ. Evaluation of cumulative prognostic scores based on the systemic inflammatory response in patients with inoperable non-small-cell lung cancer. Br J Cancer. 2003;89:1028–30.CrossRefPubMedPubMedCentral
20.
Zurück zum Zitat Onodera T, Goseki N, Kosaki G. [Prognostic nutritional index in gastrointestinal surgery of malnourished cancer patients]. Nihon Geka Gakkai zasshi. 1984;85:1001–5.PubMed Onodera T, Goseki N, Kosaki G. [Prognostic nutritional index in gastrointestinal surgery of malnourished cancer patients]. Nihon Geka Gakkai zasshi. 1984;85:1001–5.PubMed
21.
Zurück zum Zitat Zahorec R. Ratio of neutrophil to lymphocyte counts–rapid and simple parameter of systemic inflammation and stress in critically ill. Bratisl Lek Listy. 2001;102:5–14.PubMed Zahorec R. Ratio of neutrophil to lymphocyte counts–rapid and simple parameter of systemic inflammation and stress in critically ill. Bratisl Lek Listy. 2001;102:5–14.PubMed
22.
Zurück zum Zitat Liaw FY, Huang CF, Chen WL, Wu LW, Peng TC, Chang YW, et al. Higher platelet-to-lymphocyte ratio increased the risk of sarcopenia in the community-dwelling older adults. Sci Rep. 2017;7:16609.CrossRefPubMedPubMedCentral Liaw FY, Huang CF, Chen WL, Wu LW, Peng TC, Chang YW, et al. Higher platelet-to-lymphocyte ratio increased the risk of sarcopenia in the community-dwelling older adults. Sci Rep. 2017;7:16609.CrossRefPubMedPubMedCentral
23.
Zurück zum Zitat Chan AW, Chan SL, Wong GL, Wong VW, Chong CC, Lai PB, et al. Prognostic nutritional index (PNI) predicts tumor recurrence of very early/early stage hepatocellular carcinoma after surgical resection. Ann Surg Oncol. 2015;22:4138–48.CrossRefPubMed Chan AW, Chan SL, Wong GL, Wong VW, Chong CC, Lai PB, et al. Prognostic nutritional index (PNI) predicts tumor recurrence of very early/early stage hepatocellular carcinoma after surgical resection. Ann Surg Oncol. 2015;22:4138–48.CrossRefPubMed
24.
Zurück zum Zitat Chiang SF, Hung HY, Tang R, Changchien CR, Chen JS, You YT, et al. Can neutrophil-to-lymphocyte ratio predict the survival of colorectal cancer patients who have received curative surgery electively? Int J Colorectal Dis. 2012;27:1347–57.CrossRefPubMed Chiang SF, Hung HY, Tang R, Changchien CR, Chen JS, You YT, et al. Can neutrophil-to-lymphocyte ratio predict the survival of colorectal cancer patients who have received curative surgery electively? Int J Colorectal Dis. 2012;27:1347–57.CrossRefPubMed
25.
Zurück zum Zitat Shirai Y, Shiba H, Sakamoto T, Horiuchi T, Haruki K, Fujiwara Y, et al. Preoperative platelet to lymphocyte ratio predicts outcome of patients with pancreatic ductal adenocarcinoma after pancreatic resection. Surgery. 2015;158:360–5.CrossRefPubMed Shirai Y, Shiba H, Sakamoto T, Horiuchi T, Haruki K, Fujiwara Y, et al. Preoperative platelet to lymphocyte ratio predicts outcome of patients with pancreatic ductal adenocarcinoma after pancreatic resection. Surgery. 2015;158:360–5.CrossRefPubMed
26.
Zurück zum Zitat Takeda T, Sasaki T, Okamoto T, Ishitsuka T, Yamada M, Nakagawa H, et al. Prognostic impact of osteosarcopenia in patients with advanced pancreatic cancer receiving gemcitabine plus nab-paclitaxel. Pancreatology. 2023;23:275–82.CrossRefPubMed Takeda T, Sasaki T, Okamoto T, Ishitsuka T, Yamada M, Nakagawa H, et al. Prognostic impact of osteosarcopenia in patients with advanced pancreatic cancer receiving gemcitabine plus nab-paclitaxel. Pancreatology. 2023;23:275–82.CrossRefPubMed
27.
Zurück zum Zitat Yanagaki M, Haruki K, Taniai T, Igarashi Y, Yasuda J, Furukawa K, et al. The significance of osteosarcopenia as a predictor of the long-term outcomes in hepatocellular carcinoma after hepatic resection. J Hepatobiliary Pancreat Sci. 2023;30:453–61.CrossRefPubMed Yanagaki M, Haruki K, Taniai T, Igarashi Y, Yasuda J, Furukawa K, et al. The significance of osteosarcopenia as a predictor of the long-term outcomes in hepatocellular carcinoma after hepatic resection. J Hepatobiliary Pancreat Sci. 2023;30:453–61.CrossRefPubMed
28.
Zurück zum Zitat Straub RH, Cutolo M, Pacifici R. Evolutionary medicine and bone loss in chronic inflammatory diseases–a theory of inflammation-related osteopenia. Semin Arthritis Rheum. 2015;45:220–8.CrossRefPubMedPubMedCentral Straub RH, Cutolo M, Pacifici R. Evolutionary medicine and bone loss in chronic inflammatory diseases–a theory of inflammation-related osteopenia. Semin Arthritis Rheum. 2015;45:220–8.CrossRefPubMedPubMedCentral
29.
Zurück zum Zitat Cain CJ, Rueda R, McLelland B, Collette NM, Loots GG, Manilay JO. Absence of sclerostin adversely affects B-cell survival. J Bone Miner Res. 2012;27:1451–61.CrossRefPubMed Cain CJ, Rueda R, McLelland B, Collette NM, Loots GG, Manilay JO. Absence of sclerostin adversely affects B-cell survival. J Bone Miner Res. 2012;27:1451–61.CrossRefPubMed
30.
Zurück zum Zitat Lu H, Ouyang W, Huang C. Inflammation, a key event in cancer development. Mol Cancer Res. 2006;4:221–33.CrossRefPubMed Lu H, Ouyang W, Huang C. Inflammation, a key event in cancer development. Mol Cancer Res. 2006;4:221–33.CrossRefPubMed
31.
Zurück zum Zitat Seubwai W, Wongkham C, Puapairoj A, Khuntikeo N, Wongkham S. Overexpression of vitamin D receptor indicates a good prognosis for cholangiocarcinoma: implications for therapeutics. Cancer. 2007;109:2497–505.CrossRefPubMed Seubwai W, Wongkham C, Puapairoj A, Khuntikeo N, Wongkham S. Overexpression of vitamin D receptor indicates a good prognosis for cholangiocarcinoma: implications for therapeutics. Cancer. 2007;109:2497–505.CrossRefPubMed
32.
Zurück zum Zitat Casadei-Gardini A, Filippi R, Rimini M, Rapposelli IG, Fornaro L, Silvestris N, et al. Effects of metformin and vitamin D on clinical outcome in cholangiocarcinoma patients. Oncology. 2021;99:292–9.CrossRefPubMed Casadei-Gardini A, Filippi R, Rimini M, Rapposelli IG, Fornaro L, Silvestris N, et al. Effects of metformin and vitamin D on clinical outcome in cholangiocarcinoma patients. Oncology. 2021;99:292–9.CrossRefPubMed
33.
Zurück zum Zitat Fearon K, Strasser F, Anker SD, Bosaeus I, Bruera E, Fainsinger RL, et al. Definition and classification of cancer cachexia: an international consensus. Lancet Oncol. 2011;12:489–95.CrossRefPubMed Fearon K, Strasser F, Anker SD, Bosaeus I, Bruera E, Fainsinger RL, et al. Definition and classification of cancer cachexia: an international consensus. Lancet Oncol. 2011;12:489–95.CrossRefPubMed
34.
Zurück zum Zitat Fujiwara N, Nakagawa H, Kudo Y, Tateishi R, Taguri M, Watadani T, et al. Sarcopenia, intramuscular fat deposition, and visceral adiposity independently predict the outcomes of hepatocellular carcinoma. J Hepatol. 2015;63:131–40.CrossRefPubMed Fujiwara N, Nakagawa H, Kudo Y, Tateishi R, Taguri M, Watadani T, et al. Sarcopenia, intramuscular fat deposition, and visceral adiposity independently predict the outcomes of hepatocellular carcinoma. J Hepatol. 2015;63:131–40.CrossRefPubMed
36.
Zurück zum Zitat Hu L, Liu R, Zhang L. Advance in bone destruction participated by JAK/STAT in rheumatoid arthritis and therapeutic effect of JAK/STAT inhibitors. Int Immunopharmacol. 2022;111: 109095.CrossRefPubMed Hu L, Liu R, Zhang L. Advance in bone destruction participated by JAK/STAT in rheumatoid arthritis and therapeutic effect of JAK/STAT inhibitors. Int Immunopharmacol. 2022;111: 109095.CrossRefPubMed
Metadaten
Titel
Osteosarcopenia is a significant predictor of recurrence and the prognosis after resection for extrahepatic bile duct cancer
verfasst von
Michinori Matsumoto
Shinji Onda
Yosuke Igarashi
Ryoga Hamura
Tadashi Uwagawa
Kenei Furukawa
Yoshihiro Shirai
Takeshi Gocho
Koichiro Haruki
Toru Ikegami
Publikationsdatum
12.09.2023
Verlag
Springer Nature Singapore
Erschienen in
Surgery Today / Ausgabe 5/2024
Print ISSN: 0941-1291
Elektronische ISSN: 1436-2813
DOI
https://doi.org/10.1007/s00595-023-02747-0

Neu im Fachgebiet Chirurgie

Op.-Entscheidung bei Divertikulitis: Lebensqualität zählt!

Soll man Menschen, die schon mehrfach schmerzhafte Divertikulitisepisoden durchgemacht haben, eine Op. anbieten? Ein Team aus Helsinki rät, dies von der Lebensqualität abhängig zu machen.

Akute Cholezystitis bei multimorbiden Älteren: Operation nicht sofort ausschließen!

Bei älteren, multimorbiden Menschen mit akuter Cholezystitis wird eine Operation häufig nicht erwogen. Eine Studie aus Philadelphia zeigt nun jedoch, dass auch diese Patientinnen und Patienten von einer chirurgischen Therapie profitieren können.

Was geschehen muss, damit Prähabilitation in die Leitlinien kommt

Eine Prähabilitation vor einem viszeralchirurgischen Eingriff ist Experten zufolge äußerst sinnvoll, dennoch wird sie in Leitlinien derzeit nicht empfohlen. Beim DCK erklärte Prof. Tim Vilz aus Bonn, woran das liegt und was benötigt wird, um die Situation zu ändern.

Thoracic-Outlet-Syndrom nur in Ausnahmefällen operieren!

Das Thoracic-Outlet-Syndrom erfordert nur in ganz bestimmten Fällen ein operatives Vorgehen. Beim DCK wurde vor schwerwiegenden Komplikationen des anspruchsvollen Eingriffs gewarnt.

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.